Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01783418
Other study ID # 3550
Secondary ID
Status Completed
Phase N/A
First received January 29, 2013
Last updated December 7, 2015
Start date August 2012
Est. completion date September 2014

Study information

Verified date December 2015
Source St. Justine's Hospital
Contact n/a
Is FDA regulated No
Health authority Canada: Canadian Institutes of Health Research
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effects of a mindfulness-based meditation intervention on quality of life, sleep and mood in adolescents with cancer compared to a control group.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria:

- Teenagers (ages 12-18) with cancer

Exclusion Criteria:

- No ongoing or lifetime severe psychopathology, such as schizophrenia, psychosis, delusional disorders or organic mental disorders

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness Intervention
Mindfulness-based intervention adapted for teenagers

Locations

Country Name City State
Canada CHU Sainte-Justine, Mother and Child University Hospital Center Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
St. Justine's Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention Beck Youth Inventory - Anxiety scale Subscale range: 0 (minimum score) - 60 (maximum score)
Higher scores indicate higher anxiety and a worse outcome
Baseline, Post-intervention (8 weeks) No
Primary Changes in Quality of Life From Baseline to Post-intervention and 6 Months Post-intervention Pediatric Cancer Quality of Life Inventory
Scale range: 0 (minimum score) to 108 (maximum score) Higher scores represent better outcomes
Baseline, Post-intervention (8 weeks) No
Primary Changes Sleep From Baseline to Post-intervention and 6 Months Post-intervention Pittsburgh Sleep Quality Index
Score range: 0 (minimum score) - 21 (maximum score)
Higher scores indicate worse outcomes
Baseline, Post-intervention (8 weeks) No
Primary Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention Beck youth inventories - Depression scale
Subscale range: 0 (minimum score) - 60 (maximum score)
Higher scores a worse outcome
baseline, Post-intervention (8 weeks) No
Primary Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention PANAS-C - Positive affect
Score range: 0 (minimum score) - 50 (maximum score)
High scores represent better outcomes
baseline, Post-intervention (8 weeks) No
Primary Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention PANAS-C - Negative affect
Score range: 0 (minimum score) - 50 (maximum score) Higher scores represent worse outcomes
Baseline, Post-intervention (8 weeks) No
Secondary Changes in Mindfulness Propensity and Skills From Baseline to Post-intervention and 6 Months Post-intervention Children and Adolescent Mindfulness Measure Score range: 0 (minimum score) - 40 (maximum score)
Higher scores represent better outcomes
Baseline, Post-intervention (8 weeks) No
See also
  Status Clinical Trial Phase
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Not yet recruiting NCT06335745 - PediCARE Health Equity Intervention in High-Risk Neuroblastoma N/A
Withdrawn NCT04719416 - Relaxation Therapy in Pediatric Oncology N/A
Completed NCT01645436 - Physical Activity in Pediatric Cancer (PAPEC) N/A
Completed NCT04409301 - Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation N/A
Completed NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting NCT05425043 - Granulocyte Transfusions After Umbilical Cord Blood Transplant N/A
Recruiting NCT05071859 - Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study
Recruiting NCT03241251 - Screening for Psychosocial Risk in Flemish Families of a Child With Cancer
Recruiting NCT05384288 - Response to Influenza Vaccination in Pediatric Oncology Patients
Completed NCT04586491 - The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients N/A
Recruiting NCT05569512 - Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML Phase 1/Phase 2
Enrolling by invitation NCT05294380 - Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Completed NCT02665819 - Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility. N/A
Completed NCT02675166 - Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes
Not yet recruiting NCT05454163 - Post-radiotherapy Rhinosinusitis in Children
Terminated NCT02536183 - A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Phase 1
Withdrawn NCT01828502 - Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer Phase 2
Completed NCT02032121 - Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors N/A
Completed NCT03964259 - Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia Phase 1